COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

ICCVAM Logo

ICCVAM Biennial Report 2018-2019

ICCVAM Biennial Report 2018-2019
Menu

About ICCVAM and NICEATM

ICCVAM is supported by the National Toxicology Program Interagency Center for the Evaluation of Alternative Methods (NICEATM). The two groups work collaboratively to evaluate new and improved testing approaches applicable to the needs of U.S. federal agencies. The articles below provide background information on ICCVAM and NICEATM.
ICCVAM Establishment and Purpose

U.S. regulatory agencies are charged to protect human and animal health and the environment. To do this, agencies must determine the hazards presented by substances such as pesticides, consumer products, and workplace chemicals. Testing these substances provides information about possible hazards and enables informed decisions about responsible use, storage, and disposal.

Many currently accepted test methods use laboratory animals. Alternative test methods are methods that replace animal use with non-animal test systems or lower species, reduce the number of animals required for a specific test procedure, or refine animal use to enhance animal well-being and lessen or avoid pain and distress. Collectively, the principles of replacement, reduction, or refinement of animal use for scientific research or product safety testing are referred to as the 3Rs. More recently, the term “new approach methodologies” has been adopted as a broadly descriptive reference to any non-animal technology, methodology, approach, or combination of these that can be used to provide information on chemical hazard and risk assessment.

The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) established the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) to

“establish, wherever feasible, guidelines, recommendations, and regulations that promote the regulatory acceptance of new or revised scientifically valid safety testing methods that protect human and animal health and the environment while reducing, refining, and replacing animal tests and ensuring human safety and product effectiveness.”

The ICCVAM Authorization Act states that the purposes of ICCVAM are to:

  • Increase the efficiency and effectiveness of federal agency test method review.
  • Eliminate unnecessary duplicative efforts and share experiences between federal regulatory agencies.
  • Optimize utilization of scientific expertise outside the federal government.
  • Ensure that new and revised test methods are validated to meet the needs of federal agencies.
  • Reduce, refine, and replace the use of animals in testing, where feasible.

ICCVAM is a permanent interagency committee of NIEHS under the National Toxicology Program Interagency Center for the Evaluation of Alternative Methods (NICEATM).

Tags:
ICCVAM Member Agencies
  • Agency for Toxic Substances and Disease Registry (ATSDR)
  • National Cancer Institute (NCI)
  • National Institute for Occupational Safety and Health (NIOSH)
  • National Institute of Environmental Health Sciences (NIEHS)
  • National Institute of Standards and Technology (NIST)
  • National Institutes of Health (NIH)
  • National Library of Medicine (NLM)
  • Occupational Safety and Health Administration (OSHA)
  • U.S. Consumer Product Safety Commission (CPSC)
  • U.S. Department of Agriculture (USDA)
  • U.S. Department of Defense (DoD)
  • U.S. Department of Energy (DOE)
  • U.S. Department of the Interior (DOI)
  • U.S. Department of Transportation (DOT)
  • U.S. Environmental Protection Agency (EPA)
  • U.S. Food and Drug Administration (FDA)
Tags:
ICCVAM Duties and Activities

The ICCVAM Authorization Act directs ICCVAM to carry out the following duties:

  • Coordinate the technical review and evaluation of new, revised, or alternative test methods.
  • Foster interagency and international harmonization of test protocols that encourage replacing, reducing, and refining animal test methods.
  • Assist with and provide guidance on validation criteria and processes.
  • Promote the acceptance of scientifically valid test methods.
  • Promote awareness of accepted test methods.
  • Submit ICCVAM test method recommendations to appropriate U.S. federal agencies.
  • Consider requests from the public to review and evaluate new, revised, or alternative test methods that have evidence of scientific validity.
  • Make ICCVAM’s final test recommendations available to the public.
  • Prepare reports on ICCVAM progress and accomplishments under the Act and make them available to the public.
Tags:
How NICEATM Supports ICCVAM

NICEATM, an office within the NIEHS Division of NTP, provides technical and scientific support for ICCVAM and ICCVAM workgroup activities, peer review panels, expert panels, workshops, and validation efforts.

In addition to providing support for ICCVAM, NICEATM:

  • Supports NTP activities, especially those contributing to the U.S. government’s interagency Tox21 initiative.
  • Conducts analyses and evaluations, and coordinates independent validation studies on novel and high-priority alternative testing approaches.
  • Provides information to test method developers, regulators, and regulated industry through its website and workshops on topics of interest.

NICEATM Staff

NIEHS

Warren Casey, Ph.D., DABT, Senior Toxicologist; Director
Nicole Kleinstreuer, Ph.D., Deputy Director
Elizabeth Maull, Ph.D., Toxicologist
Matthew Stout, Ph.D., Toxicologist, Project Officer

NICEATM Contract Staff (Integrated Laboratory Systems, Inc.)

David Allen, Ph.D., Principal Investigator
Steven Morefield, M.D., Project Manager
Jaleh Abedini, M.S.
Shannon Bell, Ph.D.
Patricia Ceger, M.S., DABT
Xiaoqing Chang, Ph.D., DABT
Neepa Choksi, Ph.D.
Amber Daniel, M.S.
Jon Hamm, Ph.D.
Agnes Karmaus, Ph.D.
Isabel Lea, Ph.D.
Kamel Mansouri, Ph.D.
Jason Phillips (subcontractor, Sciome LLC)
John Rooney, Ph.D.
Catherine Sprankle, M.S.
Judy Strickland, Ph.D., DABT
James Truax, M.S.

Tags:
ICCVAM Advisory Committee

The ICCVAM Authorization Act established the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM). SACATM advises the Director of NIEHS, NICEATM, and ICCVAM about NICEATM and ICCVAM activities.

SACATM, which is directed by its charter to meet at least once each fiscal year, met in September 2018 and September 2019.

Roster of SACATM Members 2018-2019

Name

Title

Company

Appointment End Year

Michael B. Bolger, Ph.D.

Chief Scientist

Simulations Plus, Inc., Lancaster, CA

2020

Joseph L. Charest, Ph.D.

Biomedical Solutions Program Manager

The Charles Stark Draper Laboratory, Inc., Cambridge, MA

2022

Amy Clippinger, Ph.D.

Director

PETA International Science Consortium Ltd., Washington, DC

2022

Kelly P. Coleman, Ph.D., DABT, RAC

Distinguished Scientist and Technical Fellow

Medtronic PLC, Minneapolis, MN

2020

K. Nadira De Abrew, Ph.D.

Senior Scientist (Toxicologist)

The Procter & Gamble Company, Cincinnati, OH

2022

Sean C. Gehen, Ph.D., DABT

Regulatory Sciences Team Leader

Corteva Agriscience, Indianapolis, IN

2022

Hisham K. Hamadeh, Ph.D., DABT, M.B.A.

Vice President, Global Head of Data Sciences

Genmab US, Inc., Princeton, NJ

2019

William P. Janzen

Executive Director of Lead Discovery

Epizyme, Inc., Cambridge, MA

2018

Lawrence Milchak, Ph.D., DABT

Senior Manager, Toxicology and Strategic Services

3M Corporation, St. Paul, MN

2019

Pamela Spencer, Ph.D., DABT

Director of Regulatory and Product Stewardship

ANGUS Chemical Company, Buffalo Grove, IL

2019

ClarLynda Williams-Devane, Ph.D.

Associate Professor of Mathematics and Computer Science; Discipline Coordinator of Bioinformatics

Fisk University
Nashville, TN

2020

Wei Xu, Ph.D.

Associate Professor, Department of Oncology

McArdle Laboratory for Cancer Research, University of Wisconsin at Madison,
Madison, WI

2018

Hao Zhu, Ph.D.

Assistant Professor, Department of Chemistry

Rutgers University, Camden, NJ

2019

 

Tags: